News
HHS cancels $590 million contract with Moderna for bird flu vaccine
The US Department of Health and Human Services is terminating a contract with drugmaker Moderna to develop a vaccine to protect against bird flu amid the agency’s broader efforts to reevaluate therapies that use mRNA technology.
The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential pandemic influenza viruses, including H5N1 bird flu.
The Trump administration has cancelled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans, as well as the right to purchase shots, according to the ...
canceling a nearly $600-million contract to the drugmaker Moderna that was intended to develop a shot for humans against bird flu. The decision also forfeited the U.S. government’s right to ...
U.S. Ends $600M Moderna Bird Flu Vaccine Contract THURSDAY, May 29, 2025 (HealthDay News) — The U.S. government has canceled a $600 million contract with Moderna to develop a vaccine for bird ...
At the end of the quarter, Moderna reported its cash position was $8.4 billion, down more than $1 billion from the end of 2024. According to the latest CDC data, H5 bird flu is widespread in ...
The Trump administration has terminated a multi-million-dollar contract with Massachusetts-based Moderna to support its late-stage development of a bird flu vaccine for humans. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback